Back
Aptevo Therapeutics Quote, Financials, Valuation and Earnings
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
31
APVO
Aptevo Therapeutics
Last Price:
0.21
Seasonality Move:
-25.41%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.Aptevo Therapeutics Price Quote
$0.21
0.00 (-12.86%)
(Updated: November 16, 2024 at 5:07 AM ET)
Aptevo Therapeutics Key Stats
Sell
31
Aptevo Therapeutics (APVO)
is a Sell
Day range:
$0.21 - $0.24
52-week range:
$0.14 - $10.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.05
P/B ratio:
0.88%
Volume:
750.6K
Avg. volume:
12M
1-year change:
-97.41%
Market cap:
$3.9M
Revenue:
$0
EPS:
$-97.25
How Much Does Aptevo Therapeutics Make?
Data Unavailable
Is Aptevo Therapeutics Growing As A Company?
Data Unavailable
Aptevo Therapeutics Stock Price Performance
-
Did Aptevo Therapeutics Stock Go Up Last Month?
Aptevo Therapeutics share price went up by 45.62% last month -
Did APVO's Share Price Rise Over The Last Year?
APVO share price fell by -97.41% over the past 1 year
What Is Aptevo Therapeutics 52-Week High & Low?
-
What Is Aptevo Therapeutics’s 52-Week High Share Price?
Aptevo Therapeutics has traded as high as $10.80 over the past 52 weeks -
What Is Aptevo Therapeutics’s 52-Week Low Share Price?
Aptevo Therapeutics has traded as low as $0.14 over the past 52 weeks
Aptevo Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aptevo Therapeutics?
-
How Much Debt Does Aptevo Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aptevo Therapeutics Have?
Cash and short term investments quarterly total is $7.8M -
What Is Aptevo Therapeutics’s Book Value Per Share?
Book value per share is 0.26
Is Aptevo Therapeutics Cash Flow Positive?
-
What Is APVO Cash Flow From Operations?
Cash flow from operations (TTM) is -$23.3M -
What Is Aptevo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $11.9M -
What Is Aptevo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Aptevo Therapeutics Return On Invested Capital
Data Unavailable
Aptevo Therapeutics Earnings Date & Stock Price
-
What Is Aptevo Therapeutics's Stock Price Today?
A single share of APVO can be purchased today for 0.21 -
What Is Aptevo Therapeutics’s Stock Symbol?
Aptevo Therapeutics trades on the nasdaq under the ticker symbol: APVO -
When Is Aptevo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Aptevo Therapeutics is scheduled on March 5, 2025 -
When Is APVO's next ex-dividend date?
Aptevo Therapeutics's next ex-dividend date is May 15, 2020 -
How To Buy Aptevo Therapeutics Stock?
You can buy Aptevo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aptevo Therapeutics Competitors
-
Who Are Aptevo Therapeutics's Competitors?
Below is a list of companies who compete with Aptevo Therapeutics or are related in some way:
Aptevo Therapeutics Dividend Yield
-
What Is APVO Dividend Yield?
Aptevo Therapeutics’s dividend yield currently is 0% -
What Is Aptevo Therapeutics’s Payout Ratio?
Aptevo Therapeutics’s payout ratio is 0% -
When Did Aptevo Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 16, 2024 -
What Is Aptevo Therapeutics’s Dividend Per Share?
Aptevo Therapeutics pays a dividend of $0.00 per share
Aptevo Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 15.79% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 8.00 |
| Upside from Last Price: | 3691.47% |